AstraZeneca's Growth Potential: 6 Reasons For A Buy Rating
AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.
Buy Rating Justified for United Airlines: Strong Financial Performance and Strategic Market Positioning
In a report released today, Tabitha Foo from DBS maintained a Buy rating on United Airlines Holdings (UAL – Research Report), with a price ...
UBS raises Knight Transportation target to $63, maintains Buy
UBS analyst Thomas Wadewitz increased the price target for Knight Transportation (NYSE: NYSE:KNX) shares to $63.00, up from ...
Buy Rating for GE Vernova Inc. Amid Record Order Growth and Share Repurchases
Wells Fargo analyst Michael Blum has maintained their bullish stance on GEV stock, giving a Buy rating today.Invest with Confidence: Follow ...
BofA starts coverage on Pony AI with ‘buy’ rating on growth drivers
Bank of America initiated coverage on autonomous mobility company Pony Ai Inc (NASDAQ:PONY) with a “Buy” rating and a price ...
9 Best Cheap Stocks to Buy Under $10
Stocks trading under $10 can be attractive for investors looking to scoop up some cheap shares. Unfortunately, quality stocks ...
Apple Stock Slapped With Another Sell Rating: What to Know
The latest Apple stock downgrade centers around iPhone sales and the weakening consumer electronics market. Here's what ...
8 Best Stocks to Buy Now With $1,000
If you have an extra $1,000 sitting in a savings or checking account, one of the best ways to earn a return on that money is ...
Benzinga.com1d
Today's Analyst Stock Ratings | Upgrades, Downgrades
UBS Maintains Buy on Netflix, Raises Price Target to $1150 Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage firms often use ratings ...